Ghent University Academic Bibliography

Your filters: cql: author="Desrosiers, Martin" or (type any "bookEditor issueEditor" and editor="Desrosiers, Martin")

Add to list
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2) : phase 3, randomised, double-blind, parallel trials

Philippe Gevaert (UGent) , Martin Desrosiers, Marjolein Cornet, Joaquim Mullol, Eugenio De Corso, Nesil Keles Turel, Jorge Maspero, Shigeharu Fujieda, Luo Zhang, Ana R Sousa, et al.

(2025) LANCET. 405(10482). p.911-926
Add to list
- Journal Article
- A1
- open access
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

Martin Desrosiers, Zuzana Diamant, Paolo Castelnuovo, Peter Hellings (UGent) , Joseph K. Han, Anju T. Peters, Jared Silver, Steven G. Smith, Abigail Fuller, Ana R. Sousa, et al.

(2024) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 14(1). p.18-31
Add to list
- Journal Article
- A1
- open access
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

Peter Hellings (UGent) , Isam Alobid, Wilma T. Anselmo‐Lima, Manuel Bernal‐Sprekelsen, Leif Bjermer, Lisa Caulley, Adam Chaker, Jannis Constantinidis, Diego M. Conti, Eugenio De Corso, et al.

(2024) ALLERGY. 79(5). p.1123-1133
Add to list
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Joaquim Mullol, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter W Hellings, Joseph K Han, Roger Jankowski, Jan Vodicka, Philippe Gevaert (UGent) , Nadia Daizadeh, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(4). p.1086-1095.e5
Add to list
- Journal Article
- A1
- open access
Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

G Walter Canonica, Arnaud Bourdin, Anju T Peters, Martin Desrosiers, Claus Bachert (UGent) , Stephan Weidinger, Eric L Simpson, Nadia Daizadeh, Zhen Chen, Siddesh Kamat, et al.

(2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 10(6). p.1515-1526
Add to list
- Journal Article
- A1
- open access
Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]

Claus Bachert (UGent) , Neil Bhattacharyya, Martin Desrosiers and Asif H. Khan

(2021) JOURNAL OF ASTHMA AND ALLERGY. 14. p.393-395
Add to list
- Journal Article
- A1
- open access
Burden of disease in chronic rhinosinusitis with nasal polyps

Claus Bachert (UGent) , Neil Bhattacharyya, Martin Desrosiers and Asif H. Khan

(2021) JOURNAL OF ASTHMA AND ALLERGY. 14. p.127-134
Add to list
Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Claire Hopkins, Martin Wagenmann, Claus Bachert (UGent) , Martin Desrosiers, Joseph K. Han, Peter W. Hellings, Stella E. Lee, Jerome Msihid, Amr Radwan, Paul Rowe, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(7). p.1087-1101
Add to list
- Journal Article
- A1
- open access
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

Tanya M. Laidlaw, Claus Bachert (UGent) , Nikhil Amin, Martin Desrosiers, Peter Hellings (UGent) , Joaquim Mullol, Jorge F. Maspero, Philippe Gevaert (UGent) , Mei Zhang, Xuezhou Mao, et al.

(2021) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY. 126(5). p.584-592.e1
Add to list
International consensus statement on allergy and rhinology : rhinosinusitis 2021

Richard R. Orlandi, Todd T. Kingdom, Timothy L. Smith, Benjamin Bleier, Adam DeConde, Amber U. Luong, David M. Poetker, Zachary Soler, Kevin C. Welch, Sarah K. Wise, et al.

(2021) INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY. 11(3). p.213-739

Academic Bibliography

Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2) : phase 3, randomised, double-blind, parallel trials

Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps : SYNAPSE 24‐week treatment‐free follow‐up

EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care

Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps

Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases

Reducing fungal exposure critical for treating rhinosinusitis with or without polyps [response to letter]

Burden of disease in chronic rhinosinusitis with nasal polyps

Efficacy of dupilumab in patients with a history of prior sinus surgery for chronic rhinosinusitis with nasal polyps

Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma

International consensus statement on allergy and rhinology : rhinosinusitis 2021

Contents

Support

Contact